Evidence map›Paper›PMID 29660794›Full record

ArticleJournal of veterinary internal medicine2018

Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy.

Yasutomo Hori, Masayuki Iguchi, Yasuhiro Heishima, Yohei Yamashita, Kensuke Nakamura, Atsushi Hirakawa, Akihito Kitade, Toshiki Ibaragi, Michio Katagi, Tamotsu Sawada and 9 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of veterinary internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.Journal of feline medicine and surgery · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 18 institutions in 2 countries.

Yasutomo HoriSchool of Veterinary Medicine, Rakuno Gakuen University, 582 Midori-machi, Bunkyodai, Ebetsu, Hokkaido, Japan.ORCID http://orcid.org/0000-0001-8333-0600
Masayuki IguchiIguchi Animal Hospital, 6-2-34 Kamijima, Naka ward, Hamamatsu, Shizuoka, Japan.
Yasuhiro HeishimaSchool of Veterinary Medicine, Rakuno Gakuen University, 582 Midori-machi, Bunkyodai, Ebetsu, Hokkaido, Japan.
Yohei YamashitaEbisu Animal Hospital, 3-3-43 Nishitaga, Taihaku ward, Sendai, Miyagi, Japan.
Kensuke NakamuraOrganization for Promotion of Tenure Track, University of Miyazaki, 1-1 Gakuenkibanadai-nishi, Miyazaki, Japan.ORCID http://orcid.org/0000-0002-1010-3228
Atsushi HirakawaPet Clinic Hallelujah, 2544-1 Nakabaru, Kasuya-machi, Kasuya County, Fukuoka, Japan.
Akihito KitadeKitade Animal Hospital, 2 Tajiri, Ichishi-cho, Tsu, Mie, Japan.
Toshiki IbaragiMiyoshi Inter Animal Hospital, 27-103 Neura Fukuya-cho, Miyoshi, Aichi, Japan.
Michio KatagiKatagi Animal Hospital, 565-5 Matoba, Kawagoe, Saitama, Japan.
Tamotsu SawadaKitanomori Animal Hospital, 17-1-35 11-Jyou, Shin-kotoni, Kita ward, Sapporo, Hokkaido, Japan.
Masashi YukiYuki Animal Hospital, 2-99 Kiba-cho, Minato-ku, Nagoya, Aichi, Japan.
Nobuyuki KannoDepartment of Veterinary Medicine, Veterinary Internal Medicine, College of Bioresource Sciences, Nihon University, 1866 Kameino, Fujisawa, Kanagawa, Japan.
Haruki InabaInaba Veterinary Hospital, 533-2 Shimojo, Fujinomiya, Shizuoka, Japan.
Noriko IsayamaUenonomori Animal Clinic, 1-5-11 Yanaka Taito ward, Tokyo, Japan.
Hideyuki OnoderaOnodera Animal Hospital, 1-10-4 Chuou, Rifu-cho, Miyagi County, Miyagi, Japan.
Naoki IwasaHashima Animal Hospital, 2-17 Asahira, Fukujyu-cho, Hashima, Gifu, Japan.
Mikio KinoLita Pet Clinic, 1-170 Matsumoto-cho, Inuyama, Aichi, Japan.
Mikihiro NarukawaMie Animal Medical Center, 1596 Nishihino-cho, Yokkaichi, Mie, Japan.
Syuhei UchidaUchida Animal Hospital, 48 Shinmeishita, Shimo-machi, Nishio, Aichi, Japan.
Fujita Animal Hospital · JPAichi Developmental Disability Center · JPFujieda Municipal General Hospital · JPHamamatsu University Hospital · JPHokkaido University Hospital · JPKagoshima University Hospital · JPKaya University · KRMatsuyama University · JPMie Chuo Medical Center · JPMiyagi University · JPMiyoshi Kasei (Japan) · JPNational Mie Hospital · JPNihon University · JPRakuno Gakuen University · JPSendai Nishitaga National Hospital · JPTaiyo Yuden (Japan) · JPUniversity of Miyazaki · JPYuki Animal Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac troponin I (cTnI) is useful for assessing hypertrophic cardiomyopathy (HCM) in cats.

objectiveTo measure plasma cTnI concentrations in healthy cats and evaluate the clinical utility of cTnI in determining the severity of HCM. ANIMALS: Clinically healthy cats (n = 88) and cats with HCM (n = 93).

methodsMulticenter prospective study. Cats with HCM, including hypertrophic obstructive cardiomyopathy at various stages, were diagnosed using echocardiography. Plasma cTnI concentrations were analyzed by a commercial laboratory. Receiver-operating characteristic curve analysis was used to evaluate the accuracy of plasma cTnI concentrations to detect HCM.

resultsThe median cTnI concentration was 0.027 ng/mL (interquartile range, 0.012-0.048 ng/mL) in healthy cats. Concentrations were significantly higher in diseased cats than in healthy controls, and concentrations were significantly higher in cats with heart failure than in asymptomatic cats. A plasma cTnI concentration of 0.163 ng/mL had a sensitivity of 62.0% and specificity of 100% when used to distinguish normal cats from asymptomatic HCM cats without left atrial dilatation. A cutoff of 0.234 ng/mL had high sensitivity (95.0%) and specificity (77.8%) for assessing heart failure. The areas under the receiver-operating characteristic curves were 0.85 and 0.93, respectively. CONCLUSIONS AND CLINICAL IMPORTANCE: Increased cTnI concentrations reflect the severity of HCM. If other causes of cardiac injury are ruled out, plasma cTnI concentration may be useful for predicting the severity of HCM in cats.

Indexed as

AnimalsBlood PressureCardiomyopathy, HypertrophicCase-Control StudiesCat DiseasesCatsEchocardiographyFemaleMaleProspective StudiesROC CurveTroponin ITroponin IbiomarkercTnIfelineheart failurehypertrophy

Identifiers

PMID29660794
PMCPMC5980312
OpenAlexW2800141046

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.